Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
01 2020
Historique:
received: 10 07 2019
revised: 27 11 2019
accepted: 09 12 2019
pubmed: 22 12 2019
medline: 18 12 2020
entrez: 22 12 2019
Statut: ppublish

Résumé

Associations of substantia nigra (SN) hyperechogenicity on transcranial sonography, olfactory dysfunction, and mild parkinsonian signs (MPS) with incident Parkinson's disease (PD) have only been studied over limited periods of follow-up and their long-term predictive properties are unclear. We aimed to prospectively assess the risk for incident PD over 10 years in community-dwelling elderly individuals with these risk markers. SN-hyperechogenicity, olfactory function, and MPS were assessed in the prospective population-based Bruneck Study (2005 in-person assessment; n = 574, aged 55-94 years). Cases of incident PD were identified at 5-year and 10-year follow-up visits. We estimated relative risks of baseline markers for incident cases. After excluding 35 cases with PD or secondary parkinsonism at baseline, a total of 20 cases of incident PD were identified from the remaining 539 participants (11 at 5 years and 9 at 10 years). Relative risks for incident PD over the 10-year follow-up period were 7.43 (2.71-20.39), 3.60 (1.48-8.78), and 5.52 (2.43-12.57) for baseline SN-hyperechogenicity, hyposmia, and mild parkinsonian signs, respectively. While risk of hyposmia for incident PD was similar for the two sequential 5-year periods studied, relative risks of SN-hyperechogenicity and MPS were higher for the first five years as compared to later. Our findings extend the established risk relationship of SN-hyperechogenicity, hyposmia, and MPS with incident PD beyond 5 years of follow-up.

Identifiants

pubmed: 31864071
pii: S1353-8020(19)30527-9
doi: 10.1016/j.parkreldis.2019.12.008
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-54

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no conflict of interest related to this work.

Auteurs

Philipp Mahlknecht (P)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Heike Stockner (H)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Kathrin Marini (K)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Arno Gasperi (A)

Department of Neurology, Hospital of Bruneck, Bruneck, Italy.

Atbin Djamshidian (A)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Peter Willeit (P)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria; Department of Public Health and Primary Care, University of Cambridge, United Kingdom.

Stefan Kiechl (S)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Johann Willeit (J)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Gregorio Rungger (G)

Department of Neurology, Hospital of Bruneck, Bruneck, Italy.

Werner Poewe (W)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Klaus Seppi (K)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. Electronic address: Klaus.Seppi@tirol-kliniken.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH